GoodRx: Is it Today’s hims & hers? 8-18-25
Podcast: Becker Private Equity & Business PodcastPublished On: Mon Aug 18 2025
Description: In this episode, Scott Becker examines GoodRx’s 30% surge after entering the weight loss drug market, the rapid growth of hims and hers, and Novo Nordisk’s move to cut prices on Ozempic as competition in the GLP-1 space intensifies.
The note was deleted
The note was saved
Your message was sent